¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"channels ratio method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arm ratio
    µÎÆÈºñ
  • axial ratio
    Ãàºñ
  • abortion ratio
    À¯»êºñ
  • age-dependency ratio
    ¿¬·ÉºÎ¾çºñ
  • air entrainment ratio
    °ø±âÀ¯ÀÔ·ü
  • air pollution ratio
    ´ë±â¿À¿°·ü
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×/Ç÷ûºñ
  • albumin-globulin ratio
    ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×¿ä¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñºñ
  • body-weight ratio
    üÁß½ÅÀåºñ
  • breathing reserve ratio
    ȯ±â¿¹ºñºñ
  • common ratio
    °øºñ
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast to noise ratio
    ´ëÁ¶´ëÀâÀ½ºñ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • method of experiment
    ½ÇÇè¹æ¹ý
  • method
    ¹æ¹ý, ¹ý
  • analytical method
    ºÐ¼®¹ý
  • blind method
    ´«°¡¸²¹ý
  • projective method
    Åõ»ç¹ý
  • reflection method
    ¹Ý»ç¹ý
  • ratio
    ºñ, À²
  • correlation ratio
    »ó°üºñ
  • inspiratory expiratory ratio
    µé¼û³¯¼ûºñÀ², ÈíÈ£±â´ëºñ
  • odds ratio
    ±³Â÷ºñ
  • scatter-maximum ratio
    ÃÖ´ë»ê¶õºñ
  • segregation ratio
    ºÐ¸®ºñ
  • sex ratio
    ¼ººñ
  • signal-to-noise ratio
    ½ÅÈ£´ëÀâÀ½ºñ
  • uptake ratio
    ¼·ÃëÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • A-G ratio
    (¢¡albumin-globulin ratio) ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • abortion ratio
    À¯»êºñ
  • age-dependency ratio
    ¿¬·ÉºÎ¾çºñ
  • air entrainment ratio
    °ø±âÀ¯ÀÔ·ü
  • air pollution ratio
    ´ë±â¿À¿°·ü
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×Ç÷ûºñ
  • albumin-globulin ratio
    ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • arm ratio
    µÎÆÈºñ
  • axial ratio
    Ãàºñ
  • benefit/risk ratio
    À¯ÀÍÀ¯ÇغñÀ²
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×´¢¼ÒÁú¼ÒÅ©·¹¾ÆÆ¼´Ñºñ
  • body-weight ratio
    üÁß½ÅÀåºñ, ¸ö¹«°ÔŰºñ
  • breathing reserve ratio
    ȯ±â¿¹ºñºñ
  • caliber ratio
    Ç÷°ü°æºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gated channels
    °ü¹® ÀÌ¿ÂÅë·Î(÷×ÖØ)
  • Ligand-gated channels
    ¸®°£µå°ü¹®(¡­Î¼Ú¦) ÀÌ¿ÂÅë·Î(¡­÷×ÖØ)
  • AC/A ratio->ratio of accommodative convergence to accommodation
    Á¶ÀýÆøÁÖºñ
  • A£¯G ratio=£¾albumin globulin ratio
    A£¯G ºñ.
  • U/S osmol ratio => urine/serum osmol ratio
    ¼Òº¯/Ç÷û ¿À½º¸ôºñ
  • DeRitis ratio
    µå¸®Æ¼½ººñÀ²
  • Donnan ratio
    µ·³­À²
  • G/N ratio
    G/Nºñ Æ÷µµ´ç°ú Áú¼ÒÀÇ ºñÀ² .
  • INR => International Normalized Ratio
    ±¹Á¦Á¤»óÈ­ºñÀ²
  • International Normalized Ratio
    ±¹Á¦Á¤»óÈ­ºñÀ²
  • International Normalized Ratio=INR
    ±¹Á¦Á¤»óÈ­ºñ
  • L/S ratio
    L/S ºñÀ²
  • OER [=oxygen enhancement ratio]
    »ê¼Ò°­È­À²
  • S-D ratio
    ¼öÃà±â-À̿ϱ⠺ñ (â¥õêÑ¢-ì¬èÐÑ¢ Ýï)
  • SNR (signal to noise ratio)
    ½ÅÈ£´ë ÀâÀ½ºñÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • growth channels
  • dextrosenitrogen ratio =DN ratio
    Æ÷µµ´çÁú¼Òºñ.
  • carbol fuchsin method ; Ziehl-Neelsen method
    Ä«¸£º¼ Ç«½Å¹ý; Áú-´ÏÀϼ¾¹ý ¡ìÇ׻꼺¿°»ö¹ý¡í.
  • air entrainment ratio
    °ø±âÀ¯ÀÔ·ü.
  • air pollution ratio
    ´ë±â¿À¿°·ü(ÊÙËô).
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î ³úô¼ö¾×/Ç÷û ºñ
  • albumin-globulin ratio =A£¯G r.
    ¾ËºÎ¹Î ±Û·ÎºÒ¸°ºñ.
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ
  • alpha/beta (¥á/¥â) ratio
    ¥á/¥â ºñ
  • arm ratio
    µÎÆÈºñ(¡­Ýï).
  • axial ratio
    Ãàºñ(õîÝï)
  • benefit/risk ratio
    À¯ÀÍ/À¯ÇغñÀ².
  • birth-death ratio
    Ãâ»ý-»ç¸Áºñ(õóßæÞÝØÌÝï).
  • birth-death ratio
    Ãâ»ý-»ç¸Áºñ(̧Ë×Ë×ËÎËÓ).
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×´¢¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñ ºñ(À²)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • brine flotation method
    ½Ä¿°¼öºÎÀ¯¹ý
  • crushing method
    ÆÄ°¢¹ý
  • dilution egg counting method
    Èñ¼®Ãæ¶õ°è»ê¹ý
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
  • squash method
    ¾ÐÂø¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • channels ratio method
    ä³Î ºñÀ²¹ý(Ýï×ËÛö)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • flux ratio method
    Çöô½º ºñÀ²¹ý(Ýï×ËÛö)
  • protein efficiency ratio method
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ¹ý(üù×ËÝïÛö)
  • absorption ratio
    Èí¼öÀ² (ýåâ¥ëÒ)
  • acceptor-control ratio
    ¼ö¿ëü Á¦¾îÀ² (â¥é»ô÷ ð¤åÙëÒ)
  • affinity ratio
    ģȭºñ(öÑûúÝï)
  • A/G ratio
    A/G ºñ (Ýï)
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ(Ýï)
  • asymmetry ratio
    ºÒ±Õµîºñ (ÝÕгÔõÝï)
  • A+T/G+C ratio
    A+T/G+C ºñ (Ýï)
  • base-pair ratio
    ¿°±â¦ ºñ(Ýï)
  • base ratio
    ¿°±âºñ(ç¤ÐñÝï)
  • coding ratio
    ºÎÈ£ºñ(ݬûÜÝï)
  • dichroic ratio
    ÀÌ»öºñ(ì£ßäÝï)
  • disequilibrium ratio
    ºÒÆòÇü ºñÀ²(ÝÕøÁû¬Ýï×Ë)
  • dissymmetry ratio
    ºÒ¿ÏÀü´ëĪ ºñÀ²(ÝÕèÇîïÓßöàÝï×Ë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cardiothoracic ratio
    ½ÉÈä(°û)ºñ, ½ÉÈä°è¼ö
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast to noise ratio
    ´ëÁ¶ÀâÀ½ºñ
  • depth to width ratio
    ±íÀÌÆøºñÀ²
  • gyromagnetic ratio
    ȸÀüÀÚ±âºñÀ²
  • heart lung ratio
    ½ÉÆó°è¼ö
  • magnetization transfer ratio [=MTR]
    ÀÚÈ­Àü´ÞºñÀ²
  • ratio
    ºñ
  • signal to noise ratio [=SNR]
    ½ÅÈ£´ëÀâÀ½ºñ
  • SNR [=signal to noise ratio]
    ½ÅÈ£´ëÀâÀ½ºñÀ²
  • uptake ratio
    ¼·ÃëÀ²
  • velocity ratio
    ¼Óµµºñ
  • acquisition method
    ȹµæ¹æ¹ý
  • bolus-tracking method
    µ¢¾î¸®ÃßÀû¹æ¹ý
  • chemical saturation method
    È­ÇÐÆ÷È­±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ROC receiver operating characteristic; receptor-operated channels; relative operating characteristic; re...
VGCC voltage-gated calcium channels
HI Method Hemagglutination Inhibiting Method; Ç÷±¸ ÀÀÁý ¾ïÁ¦¹ý
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
AR absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
KATP channels ATP sensitive K+ channels
K(Ca) channels Ca(2+)-activated K(+) channels
L/S ratio Lecithin/sphingomyelin ratio
NSCC Nonselective cation channels
ROCs Receptor-operated Ca2+ channels
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • air entrainment ratio
    °ø±â À¯ÀÔ·ü
  • benefit/risk ratio
    À¯ÀÍ/À¯ÇØ ºñÀ²
  • body-weight ratio
    üÁß ½ÅÀå ºñ
  • cardiothoracic ratio
    ½ÉÈäºñ, ½ÉÈä°û ºñ, ½ÉÈä °è¼ö
  • cell color ratio
    Ç÷±¸»ö¼Òºñ, ÀûÇ÷±¸ »ö¼Òºñ
  • child woman ratio
    ¸ð¾Æ ºñÀ²
  • crown-root ratio
    Ä¡°ü´ë Ä¡±Ùºñ
  • curative ratio
    Ä¡À¯À²
  • death ratio
    »ç¸Áºñ
    µ¿ÀǾî=
  • effective ratio
    À¯È¿À²
    ¾î´À ÇѰè±îÁö´Â ¾àÁ¦ ¿ë·®°ú À¯È¿À²Àº ºñ·ÊÇÑ´Ù. ÇѰè À̻󿡼­´Â ºÎÀÛ¿ëÀÌ ³ªÅ¸³­´Ù.
  • expansion ratio
    ÆØÃ¢ºñ
  • innervation ratio
    ½Å°æ Áö¹è ºñ
  • magnetization transfer ratio
    ÀÚÈ­ Àü´Þ ºñÀ²
  • mercuryalloy ratio
    ¼öÀº Çձݺñ
  • monocyte lymphocyte ratio
    ´Ü±¸ ¸²ÇÁ±¸ºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
M channels Voltage sensitive K channels inactivated by acetylcholine. ACh acting at muscarinic AChR's produces an internal messenger that turns off this class of K channel. A mechanism for regulating the sensitivity of cells to synaptic input.
(18 Nov 1997)
chloride channels Cell membrane glycoproteins selective for chloride ions.
(12 Dec 1998)
potassium channels Cell membrane glycoproteins selective for potassium ions.
(12 Dec 1998)
sodium channels Cell membrane glycoproteins selective for sodium ions. Fast sodium current is associated with the action potential in neural membranes.
(12 Dec 1998)
ion channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for channel gating can be a membrane potential, drug, transmitter, cytoplasmic messenger, or a mechanical deformation. Ion channels which are integral parts of ionotropic neurotransmitter receptors are not included.
(12 Dec 1998)
absolute terminal innervation ratio The number of motor endplates divided by the number of terminal axons related to them.
(05 Mar 2000)
accommodative convergence-accommodation ratio The amount of convergence (measured in prism diopters of convergence) divided by the amount of accommodation (measured in diopters) required to direct both eyes upon an object.
(05 Mar 2000)
A/G ratio <abbreviation> Albumin-globulin ratio.
(05 Mar 2000)
albumin-globulin ratio The ratio of albumin to globulin in the serum or in the urine in kidney disease; the normal ratio in the serum is approximately 1.55.
(05 Mar 2000)
ALT:AST ratio The ratio of serum alanine aminotransferase to serum aspartate aminotransferase; elevated serum levels of both enzymes characterise hepatic disease; when both levels are abnormally elevated and the ALT:AST ratio is greater than 1.0, severe hepatic necrosis or alcoholic hepatic disease is likely; when the ratio is less than 1.0, an acute non-alcoholic hepatic condition is favoured.
(05 Mar 2000)
amylase-creatinine clearance ratio A test for the diagnosis of acute pancreatitis; it is determined by measuring amylase and creatinine in serum and urine in apparently healthy individuals the renal clearance of amylase is less than 5% that of creatinine; in acute pancreatitis the ratio is said to be greater than 0.05 or 5%.
(05 Mar 2000)
aspect ratio <radiobiology> In toroidal geometry, the ratio of the major diameter (total width of the torus) to the minor diameter (width of a slice taken through one side of the ring). In inertial-confinement fusion, aspect ratio refers to the ratio of a fuel pellet's radius to its wall thickness.
(09 Oct 1997)
at/gc ratio <molecular biology> The ratio of adenine-thymine base pairs to guanine-cytosine base pairs on a DNA molecule.
(09 Oct 1997)
basic reproductive rate, ratio <epidemiology> See Reproductive Ratio.
(05 Dec 1998)
body-weight ratio Body weight (in grams) divided by stature (in centimeters).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chief method
    ÁÖ¿ä ¼ö´Ü
  • method
    ¹æ¹ý,¼ø¼­,¹æ½Ä
  • ratio
    ºñ
  • Ericsson method
    ¿¡¸¯½¼ ¹ý(Àΰø ¼öÁ¤¹ýÀÇ Çϳª)
  • Grams method
    ±×·¥ ¿°»ö¹ý(¿°»öÇÏ¿© ¼¼±ÕÀ» ¾ç¼º°ú À½¼ºÀ¸·Î ºÐ·ù ½Äº°ÇÏ´Â ¹ý ç¼
  • Monte Carlo method
    ¸óÅ×Ä«¸¦·Î¹ý(º¹ÀâÇÑ ¹°¸® Çö»óÀ» ¼öÇÐÀûÀ¸·Î Ç®±â À§ÇÏ¿© ³­ ¼ö Ç¥·ê »ç¿ëÇÏ´Â ¹æ¹ý)
  • Montessori method(system)
    (ÀÌÅ»¸®¾ÆÀÇ ¿©¼º ±³À°°¡ À̸§¿¡¼­) ¸óÅ×¼Ò¸®½Ä ±³À°¹ý(¾Æµ¿ÀÇ ÀÚÁÖ¼ºÀÇ ½ÅÀåÀ» Áß½ÃÇÑ ±³À°¹ý) m`
  • case method
    »ç·Ê ¿¬±¸¹ý;=CASE SYSTEM
  • cash ratio
    (ÀºÇàÀÇ ÁöºÒ Áغñ±ÝÀÇ ÃÑ¿¹±Ý¿¡ ´ëÇÑ)Çö±Ý ºñÀ²
  • compression ratio
    (¿£ÁøÀÇ) ¾ÐÃàºñ
  • conversion ratio
    Àüȯ ºñÀ²(Çٺп­½Ã ÇϳªÀÇ ¿øÀÚ¿¡¼­ »ý±â´Â ¿øÀÚÀÇ ¼ö
  • cost performance (ratio)
    ºñ¿ë´ë ¼º´Éºñ
  • critical path analysis (method)
    Å©¸®Æ¼Äà ÆÐ½º ºÐ¼®¹ý(ÇÁ·ÎÁ§Æ®ÀÇ °èȹ.°ü¸®¸¦ °úÇÐÀûÀ¸·Î ÇÏ´Â ¹æ¹ý)
  • direct method
    (¿Ü±¹¾îÀÇ)Á÷Á¢ ±³¼ö¹ý(¿Ü±¹¾î¸¸À¸·Î °¡¸£Ä¡¸ç ¹®¹ý ±³À°µµ ÇÏÁö ¾ÊÀ½)
  • direct ratio
    (¼ö)Á¤ºñ;Á¤ºñ·Ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á